Derma Sciences, Inc.

Derma Sciences Awarded HCPCS Code for BIOGUARD™ Conforming Bandage

Code Allows Bandage to Be Reimbursed by Medicare and Most Private Health Insurance Companies

Derma Sciences Receives CE Mark for ALGICELL® Ag

CE Certification Enables Dressing to be Sold to Growing European Advanced Wound Care Market

Derma Sciences to Present at the Noble Financial Equity Conference on June 8

Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that Edward J.

Honey-Based Ointment Heals Both Humans And Turtles

One honey-based miracle ointment is healing every wound it touches – even those on sea turtles.

Derma Sciences Announces First Quarter 2010 Results

Net Sales Rise 23% on 70% Increase in Advanced Wound Care Sales, Strong Canadian Sales
Conference Call Scheduled for Today, May 13, 2010, at 11 AM ET

Derma Sciences Opens First International Office in London

Company Responds to Strong European Demand for Advanced Wound Care Products
Maeve Kelly Appointed Managing Director, EMEA

Derma Sciences to Present at the Rodman & Renshaw Annual Global Investment Conference

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, will present at the Rodman & Renshaw Annual Global Investment Conference.

Derma Sciences Launches XTRASORB™ Foam Wound Dressing

Product Line Extension Targets $300 Million Foam Wound Dressing Market

DSC127 on America's Talking

During the Week of May 3rd, Derma Science's novel therapy, DSC127 was featured on the "America's Talking" radio program which airs on over 450 radio stations across the US, Guam and Puert